Starlight Therapy in Palliative Care
ConditionSymptom Management
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNova Scotia Health Authority
About this trial
Starlight Therapy™ has been shown to help alleviate end-of-life symptoms in Palliative Care patients and reduce the need for PRN or "as needed" medications. This study will investigate the efficacy of this intervention on the symptom of anxiety using a mixed-method analysis.
The primary investigator hypothesizes that any anti-anxiolytic effects could be caused by the Intrinsically Photosensitive Retinal Ganglion Cell neural pathway to the amygdala.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Insomnia
Anxiety
Restlessness
Dyspnea
Disqualifiers
Clinical Diagnosis of blindness
Insomnia
Anxiety
Restlessness
Trial population
Patients in an inpatient palliative care Setting who meet the specified criteria for inclusion in the study
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
Starlight Therapy
Other interventionStarlight Projector will be placed in patients' rooms and project starlight on the ceilings and walls in an effort to reduce unpleasant symptoms
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Palliative Care Patients1 intervention
Trial outcomes
Primary outcomes
1
Using Starlight Therapy to measure Change in Unpleasant Symptoms in Palliative Care Patients as measured using the ESAS (Edmonton Symptom Assessment System) Scale. On a scale of 0-10, with 0 = no symptom and 10= symptom is worst outcome possible.
Edmonton Assessment scale questionnaire will be completed before Starlight Therapy and after 2 hours.
Time frame
2 hours of Starlight TherapySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: